Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (QNRX).
- Disclosed ownership: 9%.
- Date of event: 20 Oct 2025.
INTEGRATED CORE STRATEGIES (US) LLC - 20 Oct 2025 SCHEDULE 13G Report for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (QNRX)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Integrated Core Strategies (US) LLC
- Symbol
- QNRX
- Shares outstanding
- 21,128,722 shares
- Disclosed Ownership
- 1,901,585 shares
- Ownership
- 9%
- Form type
- SCHEDULE 13G
- Filing time
- 27 Oct 2025, 16:32:22 UTC
- Date of event
- 20 Oct 2025
- Next filing
- 11 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 9% ownership in Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (QNRX) on 20 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Oct 2025, 16:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 9% | 1,901,585 | 0 | 1,901,585 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 9% | 1,901,585 | 0 | 1,901,585 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 9% | 1,901,585 | 0 | 1,901,585 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 9% | 1,901,585 | 0 | 1,901,585 | /s/ Israel A. Englander | Israel A. Englander |